Illustrative image – not actual.Bharat Biotech International Ltd (BBIL) plans to raise Rs.100 crore through private placement of shares to fund its expansion plan.
The company’s expansion plan envisages setting up a
new manufacturing facility near Hyderabad. The funds raised through the private
placement will also be used to set up a sales and marketing network and undertake
research and development in pharmacogenomics.
Presently, the promoters hold 60 per cent of the
company’s equity and financial institutions and non-resident Indians hold the
remaining 40 per cent equity. The promoters’ equity would be reduced to 50 per
cent after the private placement.
